DCT
1:20-cv-00133
Novartis Pharma Corp v. HEC Pharm Co Ltd
General
Cause of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company
PACER
1:20-cv-00133
Nature of Suit835 ANDA
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
01/08/24 - now | 28% | |
09/07/22 - 01/08/24 | 48% | |
03/11/22 - 09/07/22 | 44% | |
01/29/20 - 03/11/22 | 41% |
MagistrateChristopher J. Burke
Plaintiff
Attorney
Name | Ratings |
|---|---|
L4 A | |
L5 A | |
L5 A | |
L1 B | |
L4 B | |
L3 A | |
L2 C | |
L1 B | |
L1 B | |
L1 B | |
L1 C | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- |
No Attorneys
Defendant
Party
Name | Ratings |
|---|---|
L1 D | |
L5 E | |
L5 E | |
L3 E | |
L3 E | |
L3 E | |
L3 E | |
L3 E | |
L2 C | |
L2 C | |
L2 C | |
L2 D | |
L2 E | |
L1 E | |
L1 E | |
L1 E | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- |
No Parties
Attorney
Name | Ratings |
|---|---|
L5 A | |
L5 A | |
L5 E | |
L5 B | |
L5 E | |
L3 C | |
L1 C | |
-- -- -- | |
L4 C | |
L5 E | |
L4 E | |
L5 E | |
L5 E | |
L3 E | |
L5 E | |
L5 E | |
L2 E | |
L4 C | |
L3 C | |
L2 C | |
L2 E | |
L1 C | |
-- -- -- | |
L1 C | |
L1 B | |
L1 D | |
L1 E | |
-- -- -- | |
-- -- -- |
No Attorneys